Synonyms: S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide;N-[4-Nitro-3-(trifluoromethyl)phenyl]-(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide;Ostarine;(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;MK-2866;Andarine;Propanamide,3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phe nyl]-,(2S)-;sarM s4
CAS: 401900-40-1
MF: C19H18F3N3O6
MW: 441.36
Product Categories: APIs;Amines;Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
Chemical Properties:Pale Yellow Solid
Assay:98%
Usage:It is a potent and tissue-selective androgen receptor modulator (SARM)
Packing:foil bag or as required
Ostarine,MK-2866, Enobosarm Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients.
LGD-4033 pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
MK-677, Ibutamoren, a secretagogue a secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly
Andarine (S-4) partial agonist, intended mainly for treatment of benign prostatic hypertrophy
GW-501516 It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease
Name | CAS NO. |
MK-2866, Ostarine, Enobosarm | 841205-47-8 |
MK-677, Ibutamoren | 15972-10-0 |
LGD-4033, Ligandrol | 1165910-22-4 |
GW501516, Cardarine | 317318-70-0 |
Andarine(S4) | 401900-40-0 |
SR9009 | 1379686-30-2 |
RAD140 | 1182367-47-0 |
YK11 | 431579-34-9 |
AICAR | 2627-69-2 |